BioNano Genomics logo
BioNano Genomics BNGO
$ 0.22 2.72%

Quarterly report 2024-Q3
added 11-14-2024

report update icon

BioNano Genomics Balance Sheet 2011-2024 | BNGO

Annual Balance Sheet BioNano Genomics

2023 2022 2021 2020 2019 2018 2017 2016 2015 2014 2013 2012 2011

Net Debt

-12.2 M 788 K -19.5 M -2.04 M 2.77 M -7.49 M 5.71 M 1.38 M - - - - -

Long Term Debt

3.58 M 3.62 M 3.64 M 16.3 M - 9.03 M - 6.05 M - - - - -

Long Term Debt Current

2.16 M 2.26 M 1.47 M - 20.1 M - - - - - - - -

Total Non Current Liabilities

- - - 16.4 M 227 K 10.1 M 43.7 M 32.7 M - - - - -

Total Current Liabilities

100 M 35.9 M 21.8 M 8.94 M 26.4 M 4.52 M - - - - - - -

Total Liabilities

118 M 58.1 M 40 M 25.4 M 26.6 M 14.7 M 60.4 M 42 M - - - - -

Deferred Revenue

783 K 871 K 684 K 416 K 357 K 271 K 212 K 447 K - - - - -

Retained Earnings

-581 M -349 M -216 M -144 M -103 M -72.8 M -54.3 M -30.9 M - - - - -

Total Assets

214 M 308 M 377 M 60.4 M 30.2 M 24.8 M 10.1 M 14.8 M - - - - -

Cash and Cash Equivalents

17.9 M 5.09 M 24.6 M 38.4 M 17.3 M 16.5 M - - - - - - -

Book Value

96.2 M 249 M 337 M 35.1 M 3.61 M 10.1 M -50.2 M -27.3 M - - - - -

Total Shareholders Equity

96.2 M 249 M 337 M 35.1 M 3.61 M 10.1 M -50.2 M - - - - - -

All numbers in USD currency

Quarterly Balance Sheet BioNano Genomics

2024-Q3 2024-Q2 2024-Q1 2023-Q4 2023-Q3 2023-Q2 2023-Q1 2022-Q4 2022-Q3 2022-Q2 2022-Q1 2021-Q4 2021-Q3 2021-Q2 2021-Q1 2020-Q4 2020-Q3 2020-Q2 2020-Q1 2019-Q4 2019-Q3 2019-Q2 2019-Q1 2018-Q4 2018-Q3 2018-Q2 2018-Q1 2017-Q4 2017-Q3 2017-Q2 2017-Q1 2016-Q4 2016-Q3 2016-Q2 2016-Q1 2015-Q4 2015-Q3 2015-Q2 2015-Q1 2014-Q4 2014-Q3 2014-Q2 2014-Q1 2013-Q4 2013-Q3 2013-Q2 2013-Q1 2012-Q4 2012-Q3 2012-Q2 2012-Q1 2011-Q4 2011-Q3 2011-Q2 2011-Q1

Long Term Debt

3.55 M 3.56 M 3.58 M 3.58 M 3.6 M 3.6 M 3.61 M 3.62 M 3.63 M - 3.64 M 3.64 M - - 14.9 M 16.3 M 16.3 M 16.3 M 16.3 M - - - 18.4 M 9.03 M 9.03 M 9.03 M 9.03 M - - - - - - - - - - - - - - - - - - - - - - - - - - - -

Total Non Current Liabilities

- - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - -

Total Liabilities

38.5 M 49 M 75.2 M 118 M 62.9 M 56.6 M 60.7 M 58.1 M 42 M - 37 M 40 M 18.1 M 10.9 M 22.1 M 25.4 M 25.4 M 25.4 M 25.4 M 26.6 M 26.6 M 26.6 M 26.6 M 14.7 M 14.7 M 14.7 M 14.7 M 17.4 M 17.4 M - - - - - - - - - - - - - - - - - - - - - - - - - -

Deferred Revenue

1.2 M 1.15 M 1.04 M 783 K 811 K 978 K 1.13 M 871 K 976 K - 1.11 M 684 K 411 K 445 K 301 K 416 K 412 K 416 K 416 K 357 K 418 K 358 K 214 K 271 K 336 K 271 K 271 K 212 K 212 K - - - - - - - - - - - - - - - - - - - - - - - - - -

Retained Earnings

-673 M -629 M -613 M -581 M -537 M -425 M -386 M -349 M -310 M - -246 M -216 M -193 M -172 M -154 M -144 M -144 M -144 M -144 M -103 M -103 M -103 M -103 M -72.8 M -72.8 M -72.8 M -72.8 M -54.3 M -54.3 M - - - - - - - - - - - - - - - - - - - - - - - - - -

Total Assets

87.4 M 129 M 158 M 214 M 182 M 271 M 292 M 308 M 324 M - 348 M 377 M 360 M 357 M 385 M 60.4 M 60.5 M 60.5 M 60.5 M 30.2 M 30.2 M 30.2 M 30.2 M 24.8 M 24.8 M 24.8 M 24.8 M 10.1 M 10.1 M - - - - - - - - - - - - - - - - - - - - - - - - - -

Cash and Cash Equivalents

8.79 M 10.4 M 15.8 M 17.9 M 34.6 M 14.9 M 4.1 M 5.09 M 28.2 M 27.2 M 24 M 24.6 M 141 M 333 M 362 M 38.4 M 38.4 M 38.4 M 38.4 M 17.3 M 17.3 M 17.3 M 17.3 M 16.5 M 16.5 M 16.5 M 16.5 M 1.02 M 1.02 M - - - - - - - - - - - - - - - - - - - - - - - - - -

Book Value

48.9 M 80.3 M 82.8 M 96.2 M 119 M 215 M 231 M 249 M 282 M - 311 M 337 M 342 M 346 M 363 M 35.1 M 35.1 M 35.1 M 35.1 M 3.61 M 3.61 M 3.61 M 3.61 M 10.1 M 10.1 M 10.1 M 10.1 M -7.22 M -7.22 M - - - - - - - - - - - - - - - - - - - - - - - - - -

Total Shareholders Equity

48.9 M 80.3 M 82.8 M 96.2 M 119 M 215 M 231 M 249 M 282 M 285 M 311 M 337 M 342 M 346 M 363 M 35.1 M 35.1 M 35.1 M 35.1 M 3.61 M 3.61 M 3.61 M 3.61 M 10.1 M 10.1 M 10.1 M 10.1 M -50.2 M -50.2 M - - -27.3 M - - - - - - - - - - - - - - - - - - - - - - -

All numbers in USD currency